Biomarkers in cancer infographic explaining tumor marker testing including diagnostic prognostic predictive and monitoring biomarkers in precision medicine

Cancer Biomarkers Explained: What They Mean and Why They Matter

What Are Cancer Biomarkers

Cancer biomarkers are measurable substances in the body that provide information about cancer.

They may be found in:

  • Blood
  • Tumor tissue
  • Urine
  • Other body fluids

Biomarkers help doctors understand:

  • Whether cancer is present
  • How aggressive it may be
  • Which treatments may work best

They are a key part of precision medicine.


Why Biomarkers Are Important

Biomarkers help doctors:

  • Choose targeted therapy
  • Predict treatment response
  • Monitor treatment progress
  • Detect recurrence
  • Estimate prognosis

They allow treatment to be more personalized.

Learn more:
Cancer Diagnosis Explained
https://helping4cancer.com/cancer-diagnosis-explained/


Types of Cancer Biomarkers

There are several types.

1. Diagnostic Biomarkers

Help detect cancer.

Example:

  • PSA for prostate cancer

2. Prognostic Biomarkers

Indicate how aggressive the cancer may be.

They help estimate outcomes regardless of treatment.


3. Predictive Biomarkers

Show whether a specific treatment is likely to work.

Example:

  • HER2 in breast cancer (predicts response to HER2-targeted therapy)
  • PD-L1 expression (predicts response to immunotherapy)

4. Monitoring Biomarkers

Used to track response to treatment or detect recurrence.

Example:

  • CEA in colon cancer
  • CA-125 in ovarian cancer

Common Cancer Biomarkers

HER2

Found in some breast and gastric cancers.

Helps guide targeted therapy decisions.


PD-L1

Used in many cancers to guide immunotherapy decisions.

Higher PD-L1 levels may predict better response to checkpoint inhibitors.

Learn more:
Immunotherapy Explained
https://helping4cancer.com/immunotherapy-explained/


EGFR

Common in lung cancer.

Helps guide targeted therapies.


BRAF

Seen in melanoma and some colon cancers.

Guides targeted treatment options.


KRAS

Common in colorectal and lung cancers.

May predict resistance to certain therapies.


Tumor Markers vs Genetic Testing

Tumor markers are usually proteins measured in blood.

Genetic biomarkers involve DNA changes inside tumor cells.

Genetic testing looks for:

  • Mutations
  • Gene amplifications
  • Gene fusions

Learn more:
Genetic Testing for Cancer
https://helping4cancer.com/genetic-testing-for-cancer/


How Biomarker Testing Is Done

Testing may involve:

  • Blood tests
  • Biopsy samples
  • Liquid biopsy (circulating tumor DNA)

Results help guide treatment planning.


Are Biomarkers the Same as a Cancer Diagnosis

No.

Biomarkers do not always confirm cancer by themselves.

They are used alongside:

  • Imaging
  • Biopsy
  • Pathology

Diagnosis requires multiple steps.


Can Biomarkers Change Over Time

Yes.

As cancer evolves, biomarker profiles can change.

This may affect treatment response.

Doctors sometimes repeat testing during treatment.


Key Takeaways

Cancer biomarkers provide information about tumor behavior and treatment response.

They guide targeted therapy and immunotherapy decisions.

They are essential in modern precision oncology.

Testing may involve blood or tissue samples.

Biomarkers personalize cancer treatment.


External References

National Cancer Institute – Tumor Markers
https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers

National Cancer Institute – Biomarker Testing
https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment

American Cancer Society
https://www.cancer.org/

Biomarkers in cancer infographic explaining tumor marker testing including diagnostic prognostic predictive and monitoring biomarkers in precision medicine
Medical infographic explaining cancer biomarkers including diagnostic prognostic predictive and monitoring tumor markers used in precision oncology.